L100:LSE:LSE-Lyxor UCITS FTSE 100 C-GBP (GBX)

ETF | Others |

Last Closing

USD 1374.8

Change

-4.40 (-0.32)%

Market Cap

USD 0.52B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 636.40B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 330.91B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B

ETFs Containing L100:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.34% 79% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.34% 79% B- 72% C
Trailing 12 Months  
Capital Gain 8.15% 54% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.15% 52% F 58% F
Trailing 5 Years  
Capital Gain 31.12% 55% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.12% 52% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.04% 59% D- 63% D
Dividend Return 6.04% 58% F 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.11% 58% F 73% C
Risk Adjusted Return 49.87% 67% D+ 78% C+
Market Capitalization 0.52B 71% C- 60% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike